The Food and Drug Administration (FDA) will be investigating the presence of “forever chemicals” in seafood, with the goal of understanding how such contamination contributes to dietary exposures and ...

The stock market responded positively to the company's announcement, with its share price leaping more than 28% following the ...

Attruby (acoramidis), a near complete TTR stabilizer, has been approved by FDA to reduce cardiovascular death and ...

The proposed crackdown, which is still in its early stages and will need to get a sign-off from Trump and his transition team, targets a provision in the FDA's regulations on which food additives ...

Trump also has named his picks for the FDA, the Centers for Disease Control and Prevention, and surgon general — rounding out his nominees to joing Robert F. Kennedy Jr. in radically transforming the ...

Trump, 78, nominated Dr. Marty Makary – a professor at the Johns Hopkins School of Medicine and contributor for The Post – to serve as FDA commissioner. Makary has been an outspoken critic of ...

“FDA has lost the trust of Americans and has lost sight of its primary goal as a regulator,” Trump said in a statement. Trump said Makary will work under Robert F. Kennedy Jr., whom he ...

The Food and Drug Administration (FDA) this week authorized a long-delayed clinical trial to test whether smoking marijuana can be used to treat post-traumatic stress disorder (PTSD) in veterans.

The Food and Drug Administration (FDA) will be investigating the presence of “forever chemicals” in seafood, with the goal of understanding how such contamination contributes to dietary ...

The Food and Drug Administration approved on Friday a new medicine from BridgeBio for patients with a progressive heart disease — the first new treatment for the condition in over five years and ...

President-elect Donald Trump on Friday named Dr. Marty Makary, a pancreatic surgeon at Johns Hopkins University, as his pick to lead the U.S. Food and Drug Administration (FDA), a federal agency ...

SurgePays partners with AT&T to deliver 4G LTE and 5G services, expanding into underserved markets via its MVNO strategy. The deal leverages SurgePays' distribution network for affordable wireless ...